Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Macrogen, Inc. (038290.KQ)
KRW11,650.00
+110.00 (+0.95%)
KR KOE Healthcare Biotechnology
Description
Macrogen, Inc. specializes in offering a wide array of services within genetic research and biotechnology. Their core offerings span various solutions, including whole-genome, clinical, and personalized DNA sequencing, as well as oligonucleotide synthesis, microarray analysis, and the creation of genetically engineered mice. This company was established on June 5, 1997, and its corporate headquarters are situated in Seoul, South Korea.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
KRW11,650.00
+110.00 (+0.95%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
43.2K
Beta
0.29
Float Shares
7.77M
Free Float %
71.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.52% | -3.16% | -17.78% | -23.78% | -9.62% | -18.12% | -8.68% | -29.46% | -56.62% | -62.05% | -36.10% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
11,650.00
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.30
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
1 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+43.8% ★ Q1'26: +10.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+124.6% ★ Q1'26: +80.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+0.4% Q1'26: -8.8% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+0.0% ★ Q1'26: -1.2% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+0.0% ★ Q1'26: -1.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+8.7% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×5.85× Q1'26: 7.30× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
91.10B
est.
|
102.81B
est: 101.80B (+1.0%)
|
112.60B
est: 138.90B (-18.9%)
|
138.62B
est: 151.00B (-8.2%)
|
132.80B
est: 169.00B (-21.4%)
|
135.78B
est: 181.00B (-25.0%)
|
195.27B
est: 195.00B (+0.1%)
|
241.10B
241.10B – 241.10B
+23.6% YoY
|
287.40B
287.40B – 287.40B
+19.2% YoY
|
| EBITDA |
4.00B
est.
|
17.16B
est: 4.46B (+284.3%)
|
20.71B
est: 6.09B (+240.0%)
|
-17.23B
est: 6.62B (-360.1%)
|
-8.05B
est: 7.41B (-208.6%)
|
2.11B
est: 4.50B (-53.2%)
|
17.36B
est: 4.85B (+258.3%)
|
5.99B
5.99B – 5.99B
+23.6% YoY
|
7.14B
7.14B – 7.14B
+19.2% YoY
|
| EBIT |
-4.13B
est.
|
8.46B
est: -4.62B (+283.2%)
|
7.16B
est: -6.30B (+213.7%)
|
-28.20B
est: -6.85B (-311.9%)
|
-19.25B
est: -7.66B (-151.2%)
|
-8.69B
est: -10.51B (+17.3%)
|
12.59M
est: -11.32B (+100.1%)
|
-13.99B
-13.99B – -13.99B
-23.6% YoY
|
-16.68B
-16.68B – -16.68B
-19.2% YoY
|
| Net Income |
4.81B
est.
|
17.89B
est: 8.88B (+101.4%)
|
88.34B
est: 11.48B (+669.7%)
|
-22.25B
est: 11.69B (-290.4%)
|
-16.81B
est: 15.26B (-210.2%)
|
-7.60B
est: 19.95B (-138.1%)
|
2.03B
est: -1.02B (+299.2%)
|
11.14B
11.14B – 11.14B
+1,193.6% YoY
|
24.10B
24.10B – 24.10B
+116.2% YoY
|
| SGA |
7.28B
est.
|
23.43B
est: 8.13B (+188.0%)
|
6.62B
est: 11.10B (-40.4%)
|
11.15B
est: 12.06B (-7.6%)
|
10.64B
est: 13.50B (-21.2%)
|
13.67B
est: 15.79B (-13.4%)
|
18.63B
est: 17.01B (+9.6%)
|
21.03B
21.03B – 21.03B
+23.6% YoY
|
25.07B
25.07B – 25.07B
+19.2% YoY
|
| EPS |
482.00
est.
|
1,788.72
est: 891.00 (+100.8%)
|
9,002.00
est: 1,151.00 (+682.1%)
|
-2,212.00
est: 1,172.00 (-288.7%)
|
-1,683.00
est: 1,530.00 (-210.0%)
|
-762.51
est: 1,840.00 (-141.4%)
|
187.25
est: -94.00 (+299.2%)
|
1,028.00
1,028.00 – 1,028.00
+1,193.6% YoY
|
2,223.00
2,223.00 – 2,223.00
+116.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
18.02B
OE per share TTM
1,662.42
Owner's Yield
11.79%
Maintenance CapEx ratio
64.44%
Maint CapEx / Avg PPE
53.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 5 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 58.9K | 0.39% |
| 2 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 52.4K | 0.28% |
| 3 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 3.0K | 0.46% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 10.1K | 0.29% |
| 5 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.00% | 94.36 | 0.56% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
Executive team data is not available for this company yet.
EBIT / Employee
23.8K
Shares Outstanding
10.84M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
ESG Score History
No data available for this company.
Company data will be available after the next weekly refresh.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 038290.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
